Papers by Steven A. Rosenberg
Page 10 · newest first
- In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.Journal of Clinical Oncology · 1994
- Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cellsInternational Journal of Cancer · 1994
- A Phase I Trial of Intravenous Interleukin-6 in Patients with Advanced CancerJournal of Immunotherapy · 1994
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences · 1994
- Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.The Journal of Immunology · 1994
- T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.Proceedings of the National Academy of Sciences · 1994
- Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2JAMA · 1994
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2JAMA · 1994
- Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with responseCancer · 1994
- Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.The Journal of Experimental Medicine · 1994
- A Prospective Randomized Trial Evaluating Colloid Versus Crystalloid Resuscitation in the Treatment of the Vascular Leak Syndrome Associated with Interleukin-2 TherapyJournal of Immunotherapy · 1994
- Molecular Mechanisms Used by Tumors to Escape Immune RecognitionJournal of Immunotherapy · 1993
- The Development of Gene Therapy for the Treatment of CancerAnnals of Surgery · 1993
- Use of Interleukin-7, Interleukin-2, and Interferon-γ to Propagate CD4+ T Cells in Culture with Maintained Antigen SpecificityJournal of Immunotherapy · 1993
- Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA.The Journal of Immunology · 1993
- T-Cell Recognition of Human Melanoma AntigensJournal of Immunotherapy · 1993
- Regression of Metastatic Renal Cell Carcinoma After Cytoreductive NephrectomyThe Journal of Urology · 1993
- Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.The Journal of Experimental Medicine · 1993
- The Management of Isolated Renal Recurrence of Renal Cell Carcinoma Following Complete Response to Interleukin-2 Based ImmunotherapyThe Journal of Urology · 1993
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine · 1993
- Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factorThe Journal of Immunology · 1993
- Specific Release of Cytokines by Lymphocytes Infiltrating Human Melanomas in Response to Shared Melanoma AntigensJournal of Immunotherapy · 1993
- Identification of Human Cancers Defective in Antigen ProcessingJournal of Immunotherapy · 1993
- Gene Therapy for CancerJAMA · 1992
- Recognition of Shared Melanoma Antigens by Human Tumor-Infiltrating LymphocytesJournal of Immunotherapy · 1992
- In Vivo Administration of Recombinant Macrophage Colony-Stimulating Factor Induces Macrophage-Mediated Antibody-Dependent Cytotoxicity of Tumor CellsJournal of Immunotherapy · 1992
- Characterization of Lymphocytes Infiltrating Human Breast Cancer, Specific Immune Reactivity Detected by Measuring Cytokine SecretionJournal of Immunotherapy · 1992
- Cellular mechanisms of the antitumor activity of recombinant IL-6 in miceThe Journal of Immunology · 1992
- Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapyCancer · 1992
- Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Tumor Necrosis Factor (National Institutes of Health)Human Gene Therapy · 1992
- Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health)Human Gene Therapy · 1992
- Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomasThe Journal of Immunology · 1992
- Thyroid dysfunction associated with immunotherapy for patients with cancerCancer · 1991
- Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy.The Journal of Experimental Medicine · 1991
- Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune responseThe Journal of Immunology · 1991
- Lysis of Autologous Melanoma Cells by Tumor*Infiltrating Lymphocytes: Association With Clinical ResponseJNCI Journal of the National Cancer Institute · 1991
- Common Expression of Melanoma Tumor-Associated Antigens Recognized by Human Tumor Infiltrating Lymphocytes: Analysis by Human Lymphocyte Antigen RestrictionJournal of Immunotherapy · 1991
- Cancer: Principles and Practice of Oncology.Annals of Internal Medicine · 1991
- Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumorsThe Journal of Immunology · 1991
- Lymphocytes as cellular vehicles for gene therapy in mouse and man.Proceedings of the National Academy of Sciences · 1991
- Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.The Journal of Experimental Medicine · 1991
- Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancerCancer · 1990
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine · 1990
- Antitumor activity of recombinant interleukin 6 in mice.The Journal of Experimental Medicine · 1990
- Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.Journal of Clinical Oncology · 1989
- Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.Journal of Clinical Oncology · 1989
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery · 1989
- Extremity soft tissue sarcomas: Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher‐grade sarcomasJournal of Surgical Oncology · 1989
- The Neuroendocrine Effects of Interleukin-2 TreatmentThe Journal of Clinical Endocrinology & Metabolism · 1989
- In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.The Journal of Immunology · 1989